Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Featured
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hallucinating Long After the Trip is Over: HPPD – Part 2
New Jersey Gov Signs Bill Reclassifying Psilocybin
Psychedelic Synesthesia: Smell That Tune
Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills Introduced in VT, and Ketamine Telehealth Uncertainty
Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
Field Trip Health Announces $50 Million Bought Deal Offering of Common...
PT257 – Robin Divine – Black People Trip
Awakn Life Sciences to Commence Trading on the NEO Exchange under...
COMPASS Pathways plc announces financial results and business highlights for the...
Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety...
Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use...
Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with...
FILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL
Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics,...
Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI
1
2
3
...
243
Page 1 of 243